Loading...
Market
Will Sanofi's Beijing insulin plant begin construction by end of 2025?
3
Resolution / Starting Odds
Yes • 50%
No • 50%
Sanofi press releases, official announcements, or major news outlets
Story
Sanofi's Largest China Investment: $1.1 Billion Insulin Plant in Beijing
Dec 3, 2024, 05:43 AM
Sanofi, a French pharmaceutical company, has announced plans to invest approximately $1.1 billion (€1 billion) in establishing a new insulin production facility in Beijing, marking its largest single investment in China to date. The project, which will be Sanofi's fourth production-and-supply base in the country, comes at a time of heightened China-EU trade tensions. The investment aims to boost insulin production, aligning with China's efforts to attract foreign investment amidst global economic challenges. The agreement was formalized through a Memorandum of Understanding (MoU) signed in the Beijing Economic-Technological Development Area.
View original story
Similar markets
Fully operational • 25%
Partially operational • 25%
Not operational • 25%
Other • 25%
No • 50%
Yes • 50%
Yes • 50%
No • 50%
500 to 1000 • 25%
1000 to 1500 • 25%
Less than 500 • 25%
More than 1500 • 25%
Other • 25%
No change • 25%
Improved relations • 25%
Worsened relations • 25%
Remain the same • 25%
Other • 25%
Decrease • 25%
Increase • 25%